Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-07-22 3:04 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | MFN Partners Management LP | 1,895,677 4.53% | -2,104,323 (-52.61%) | View |
| 2020-07-10 10:39 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | BlackRock Inc. BLK | 1,047,816 2.5% | -1,591,753 (-60.30%) | View |
| 2020-06-26 4:25 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,500,000 5.97% | 2,500,000 (New Position) | View |
| 2020-03-09 4:10 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | MORGAN STANLEY MS | 23,767 0.1% | -2,495,115 (-99.06%) | View |
| 2020-03-06 4:00 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Samsara BioCapital L.P. | 2,161,333 5.2% | 2,161,333 (New Position) | View |
| 2020-02-14 4:26 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | D. E. SHAW & CO L.P. | 70,501 0.2% | -2,209,793 (-96.91%) | View |
| 2020-02-14 2:09 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | EcoR1 Capital LLC | 2,087,312 5% | 2,087,312 (New Position) | View |
| 2020-02-14 1:49 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 1,600,000 3.87% | -500,000 (-23.81%) | View |
| 2020-02-13 5:19 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Broadfin Capital LLC | 1,888,039 4.56% | -392,221 (-17.20%) | View |
| 2020-02-13 4:53 pm Unchanged | 13G | ACLARIS THERAPEUTICS INC ACRS | MFN Partners Management LP | 4,000,000 9.7% | 0 (Unchanged) | View |
| 2020-02-13 12:36 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Flynn James E | 0 0% | -2,848,374 (Position Closed) | View |
| 2020-02-13 10:38 am Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | MORGAN STANLEY MS | 2,518,882 6.1% | 441,640 (+21.26%) | View |
| 2020-02-12 4:18 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | RENAISSANCE TECHNOLOGIES LLC | 2,782,297 6.72% | 2,782,297 (New Position) | View |
| 2020-02-10 4:09 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Man Group plc | 1,295,966 3.13% | -1,125,219 (-46.47%) | View |
| 2020-02-07 11:12 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | FMR LLC | 205,984 0.497% | -1,858,625 (-90.02%) | View |
| 2020-02-05 11:26 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | BlackRock Inc. BLK | 2,639,569 6.4% | -981,266 (-27.10%) | View |
| 2020-02-04 2:25 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | FRANKLIN RESOURCES INC BEN | 320 0% | -3,986,102 (-99.99%) | View |
| 2019-12-19 5:15 pm Sale | 13D | ACLARIS THERAPEUTICS INC ACRS | Arkin Moshe | 1,967,082 4.75% | -716,158 (-26.69%) | View |
| 2019-11-21 4:48 pm Sale | 13D | ACLARIS THERAPEUTICS INC ACRS | Arkin Moshe | 2,683,240 6.48% | -636,510 (-19.17%) | View |
| 2019-10-31 5:26 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | MFN Partners Management LP | 4,000,000 9.7% | 4,000,000 (New Position) | View |